News
Bill Burns Appointed as Non Executive Director
May 07 2010
Shire plc (Dublin) a specialty biopharmaceutical company has appointed Bill Burns to its Board as a Non Executive Director with immediate effect. Mr Burns has also been appointed a member of Shire’s Remuneration Committee. Mr Burns has a long and distinguished career in the global pharmaceuticals industry, most recently as CEO of Roche’s Pharmaceuticals Division and as a member of the Roche Group Corporate Executive Committee. He was involved in the acquisition and privatisation of Genentech, led the integration of Boehringer Mannheim Therapeutics and played a lead role in the negotiations resulting in Roche becoming a majority owner of Chugai in Japan. Following retirement in January this year, he has since been appointed to the Board of Directors of Roche Holdings Ltd and is a Board member of bothChugai Pharmaceuticals and of Genentech Inc.
Digital Edition
Lab Asia 32.1 Feb 2025
February 2025
Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...
View all digital editions
Events
SPS Smart Production Solutions Guangzhou
Feb 25 2025 Guanghzou, China
Feb 25 2025 Amsterdam, Netherlands
Feb 27 2025 Kathmandu, Nepal
Mar 01 2025 Boston, MA, USA
Mar 02 2025 Bethesda, MD, USA